While not yet commercially available, researchers working with this peptide follow the same injection site principles
Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study
Formerly known as polycystic ovarian syndrome, or PCOS, this hormonal condition is characterized by insulin resistance, weight gain, high testosterone levels, and irregular or absent periods
GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide
This has led some researchers to target 9mg rather than 12mg as their maintenance dose, especially given that the difference (2.3 percentage points) may not justify the additional side effect burden for all individuals
Like any medication, GLP-1s can cause side effects, especially in the early stages of treatment